Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Total Current Liabilities (2009 - 2026)

Compugen (CGEN) posted quarterly Total Current Liabilities of $22.0 million for Q1 2026, up 4.97% year-over-year from $21.0 million in Q1 2025, and down 2.36% on a QoQ basis from $22.6 million in Q4 2025.

Analysis

Compugen (CGEN) Total Current Liabilities (2009 - 2026) Analysis & Trends

Compugen has reported Total Current Liabilities for 18 years, with the latest figure at $22.0 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $22.0 million, up 4.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.0 million (up 4.97% YoY), and the FY2025 annual result was $22.6 million, up 11.95% from the prior year.
  • Total Current Liabilities eased to $22.0 million in Q1 2026, from $22.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $27.8 million in Q3 2024 and troughed at $10.4 million in Q3 2023.
  • A 5-year average of $18.7 million and a median of $20.3 million in 2025 frame the typical range for Total Current Liabilities.
  • The widest annual swing landed in 2023, when Total Current Liabilities sank 31.74%; it then soared 167.55% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $11.9 million in 2022, then surged by 120.37% to $26.3 million in 2023, then dropped by 23.25% to $20.2 million in 2024, then grew by 11.95% to $22.6 million in 2025, then declined by 2.36% to $22.0 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $22.0 million in Q1 2026, $22.6 million in Q4 2025, and $20.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 22.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.63 Mn
Mar 31, 2026 22.04 Mn
Dec 31, 2025 22.57 Mn
Sep 30, 2025 20.28 Mn
Jun 30, 2025 20.58 Mn
Mar 31, 2025 20.99 Mn
Dec 31, 2024 20.16 Mn
Sep 30, 2024 27.76 Mn
Jun 30, 2024 24.77 Mn
Mar 31, 2024 24.63 Mn
Dec 31, 2023 26.27 Mn
Sep 30, 2023 10.38 Mn
Jun 30, 2023 10.80 Mn
Mar 31, 2023 10.72 Mn
Dec 31, 2022 11.92 Mn
Sep 30, 2022 14.77 Mn
Jun 30, 2022 14.00 Mn
Mar 31, 2022 15.70 Mn
Dec 31, 2021 17.10 Mn
Sep 30, 2021 15.26 Mn